60 related articles for article (PubMed ID: 22539389)
41. Effect of resveratrol on drug resistance in colon cancer chemotherapy.
Huang L; Zhang S; Zhou J; Li X
RSC Adv; 2019 Jan; 9(5):2572-2580. PubMed ID: 35520503
[TBL] [Abstract][Full Text] [Related]
42. Verteporfin enhances the sensitivity of LOVO/TAX cells to taxol via YAP inhibition.
Shi G; Wang H; Han H; Gan J; Wang H
Exp Ther Med; 2018 Sep; 16(3):2751-2755. PubMed ID: 30210616
[TBL] [Abstract][Full Text] [Related]
43. RhoGDI2 confers resistance to 5-fluorouracil in human gastric cancer cells.
Zheng Z; He XY; Li JF; Yu BQ; Chen XH; Ji J; Zhang JN; Gu QL; Zhu ZG; Liu BY
Oncol Lett; 2013 Jan; 5(1):255-260. PubMed ID: 23255931
[TBL] [Abstract][Full Text] [Related]
44. Quantitative chemical imaging of the intracellular spatial distribution of fundamental elements and light metals in single cells.
Malucelli E; Iotti S; Gianoncelli A; Fratini M; Merolle L; Notargiacomo A; Marraccini C; Sargenti A; Cappadone C; Farruggia G; Bukreeva I; Lombardo M; Trombini C; Maier JA; Lagomarsino S
Anal Chem; 2014 May; 86(10):5108-15. PubMed ID: 24734900
[TBL] [Abstract][Full Text] [Related]
45. [Fagotherapy: Multi-drug resistance compel us to review the past].
Lopardo HA
Rev Argent Microbiol; 2017; 49(1):1-2. PubMed ID: 28385179
[No Abstract] [Full Text] [Related]
46. Outsmarting multi-drug resistance in uncertain times.
JAC Antimicrob Resist; 2020 Dec; 2(4):dlaa080. PubMed ID: 34223036
[TBL] [Abstract][Full Text] [Related]
47. Brain metastases from colorectal cancer: microenvironment and molecular mechanisms.
Zang YW; Gu XD; Xiang JB; Chen ZY
Int J Mol Sci; 2012 Nov; 13(12):15784-800. PubMed ID: 23443093
[TBL] [Abstract][Full Text] [Related]
48. Involvement of RhoGDI2 in the resistance of colon cancer cells to 5-fluorouracil.
Zheng Z; Li J; He X; Chen X; Yu B; Ji J; Zhang J; Wang T; Gu Q; Zhu Z; Liu B
Hepatogastroenterology; 2010; 57(102-103):1106-12. PubMed ID: 21410040
[TBL] [Abstract][Full Text] [Related]
49. Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer.
Tsuruta M; Nishibori H; Hasegawa H; Ishii Y; Endo T; Kubota T; Kitajima M; Kitagawa Y
Oncol Rep; 2008 Nov; 20(5):1165-72. PubMed ID: 18949417
[TBL] [Abstract][Full Text] [Related]
50. [Establishment of a human nasopharyngeal carcinoma drug-resistant cell line CNE2/DDP and screening of drug-resistant genes].
Jiang RD; Zhang LX; Yue W; Zhu YF; Lu HJ; Liu X; Cen XT; Guan XY; Li CH
Ai Zheng; 2003 Apr; 22(4):337-45. PubMed ID: 12703984
[TBL] [Abstract][Full Text] [Related]
51. [Proteomic research of biomarker of colorectal cancer metastasis].
Zhang P; Huang L; Ma YL; Peng JY; Shen TY; Chen HQ; Zhou YK; Chu ZX; Zhang M; Qin HL
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Nov; 12(6):618-22. PubMed ID: 19921578
[TBL] [Abstract][Full Text] [Related]
52. [Establishment of a human laryngeal carcinoma Hep-2/5-Fu cell line and the screening of differentially expressed genes].
Chen J; Wang J
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Dec; 26(24):1130-3. PubMed ID: 23477120
[TBL] [Abstract][Full Text] [Related]
53. [Screening and identification of genes associated with multi-drug resistance in colonic cancer].
Li JF; Zheng Z; Yu BQ; Qu Y; Zhu ZG; Liu BY
Zhonghua Wei Chang Wai Ke Za Zhi; 2012 Apr; 15(4):388-91. PubMed ID: 22539389
[TBL] [Abstract][Full Text] [Related]
54.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
55.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
